» Articles » PMID: 32863846

Metabolic and Clinical Responses to Bunium Persicum (black Caraway) Supplementation in Overweight and Obese Patients with Type 2 Diabetes: a Double-blind, Randomized Placebo-controlled Clinical Trial

Overview
Publisher Biomed Central
Date 2020 Sep 1
PMID 32863846
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes mellitus is the most common metabolic disorder worldwide. We aimed to determine the metabolic and clinical responses to Bunium Persicum (Black Caraway) supplementation in overweight and obese patients with T2DM.

Methods: Participant recruitment took place in the diabetic clinic of Bu-Ali hospital in Zahedan. Due to the eligibility criteria, 60 participants were randomly placed into two groups, namely placebo ( = 30) and BP ( = 30). The supplementation was considered one 1000 mg capsule 2 times /day BP by meals (lunch and dinner) for 8 weeks. Physical activity levels, dietary intakes, anthropometric measurements [weight, height, and waist circumference], glycemic indices [fasting blood glucose (FBG) and insulin (FBI)], blood lipids [triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c)], and serum nesfatin-1 level were determined. Homeostasis model assessment-insulin resistance (HOMA-IR), Quantitative insulin sensitivity checks index (QUICKI), and Body Mass Index (BMI) were computed.

Results: In comparison with placebo, BP significantly decreased FBG, HOMA-IR, and BMI (). The differences in the FBI, QUICKI, TG, TC, LDL, HDL, WC, and Nesfatin-1 were not significant ().

Conclusion: BP supplementation improved serum glucose indices and BMI among overweight and obese T2DM patients. Further trials are needed to confirm results.

Trial Registration: Iranian Registry of Clinical Trials (IRCT), IRCT20181207041876N1, Registered 18/01/2019, https://irct.ir/trial/35752.

Citing Articles

The biological functions and pathological mechanisms of CASK in various diseases.

Liu X, Qin H, Liu Y, Ma J, Li Y, He Y Heliyon. 2024; 10(8):e28863.

PMID: 38638974 PMC: 11024568. DOI: 10.1016/j.heliyon.2024.e28863.


Nesfatin-1 - as a diagnosis regulatory peptide in type 2 diabetes mellitus.

Kadim B, Hassan E J Diabetes Metab Disord. 2022; 21(2):1369-1375.

PMID: 36404867 PMC: 9672287. DOI: 10.1007/s40200-022-01070-8.


Fufang Fanshiliu Decoction Revealed the Antidiabetic Effect through Modulating Inflammatory Response and Gut Microbiota Composition.

Li L, Huang G, Chen T, Lin H, Xu R, Cheng J Evid Based Complement Alternat Med. 2022; 2022:3255401.

PMID: 36262166 PMC: 9576391. DOI: 10.1155/2022/3255401.

References
1.
Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y . Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf). 2010; 73(4):484-90. DOI: 10.1111/j.1365-2265.2010.03835.x. View

2.
Ozturk Ozkan G . Effects of Nesfatin-1 on Food Intake and Hyperglycemia. J Am Coll Nutr. 2019; 39(4):345-351. DOI: 10.1080/07315724.2019.1646678. View

3.
Sharififar F, Yassa N, Mozaffarian V . Bioactivity of major components from the seeds of Bunium persicum (Boiss.) Fedtch. Pak J Pharm Sci. 2010; 23(3):300-4. View

4.
Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A . The Growing Epidemic of Diabetes Mellitus. Curr Vasc Pharmacol. 2019; 18(2):104-109. DOI: 10.2174/1570161117666190405165911. View

5.
Giancarlo S, Rosa L, Nadjafi F, Francesco M . Hypoglycaemic activity of two spices extracts: Rhus coriaria L. and Bunium persicum Boiss. Nat Prod Res. 2006; 20(9):882-6. DOI: 10.1080/14786410500520186. View